1 Study Coverage 1.1 Lentiviral Vector In Gene Therapy Product Introduction 1.2 Market by Type 1.2.1 Global Lentiviral Vector In Gene Therapy Market Size Growth Rate by Type 1.2.2 Retrovirus (RV) 1.2.3 Adenovirus (AdV) 1.2.4 Adeno-associated Virus (AAV) 1.3 Market by Application 1.3.1 Global Lentiviral Vector In Gene Therapy Market Size Growth Rate by Application 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Research Institution 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Lentiviral Vector In Gene Therapy Market Size, Estimates and Forecasts 2.1.1 Global Lentiviral Vector In Gene Therapy Revenue 2016-2027 2.1.2 Global Lentiviral Vector In Gene Therapy Sales 2016-2027 2.2 Global Lentiviral Vector In Gene Therapy, Market Size by Region: 2016 VS 2021 VS 2027 2.3 Lentiviral Vector In Gene Therapy Historical Market Size by Region (2016-2021) 2.3.1 Global Lentiviral Vector In Gene Therapy Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global Lentiviral Vector In Gene Therapy Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 Lentiviral Vector In Gene Therapy Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Lentiviral Vector In Gene Therapy Sales Forecast by Region (2022-2027) 2.4.2 Global Lentiviral Vector In Gene Therapy Revenue Forecast by Region (2022-2027) 3 Global Lentiviral Vector In Gene Therapy Competitor Landscape by Players 3.1 Global Top Lentiviral Vector In Gene Therapy Manufacturers by Sales 3.1.1 Global Lentiviral Vector In Gene Therapy Sales by Manufacturer (2016-2021) 3.1.2 Global Lentiviral Vector In Gene Therapy Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Lentiviral Vector In Gene Therapy Manufacturers by Revenue 3.2.1 Key Lentiviral Vector In Gene Therapy Manufacturers Covered: Ranking by Revenue 3.2.2 Global Lentiviral Vector In Gene Therapy Revenue by Manufacturers (2016-2021) 3.2.3 Global Lentiviral Vector In Gene Therapy Revenue Share by Manufacturers (2016-2021) 3.2.4 Global Lentiviral Vector In Gene Therapy Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by Lentiviral Vector In Gene Therapy Revenue in 2020 3.2.6 Global Lentiviral Vector In Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Lentiviral Vector In Gene Therapy Price by Manufacturers 3.4 Global Lentiviral Vector In Gene Therapy Manufacturing Base Distribution, Product Types 3.4.1 Lentiviral Vector In Gene Therapy Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Lentiviral Vector In Gene Therapy Product Type 3.4.3 Date of International Manufacturers Enter into Lentiviral Vector In Gene Therapy Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global Lentiviral Vector In Gene Therapy Market Size by Type (2016-2021) 4.1.1 Global Lentiviral Vector In Gene Therapy Sales by Type (2016-2021) 4.1.2 Global Lentiviral Vector In Gene Therapy Revenue by Type (2016-2021) 4.1.3 Lentiviral Vector In Gene Therapy Average Selling Price (ASP) by Type (2016-2021) 4.2 Global Lentiviral Vector In Gene Therapy Market Size Forecast by Type (2022-2027) 4.2.1 Global Lentiviral Vector In Gene Therapy Sales Forecast by Type (2022-2027) 4.2.2 Global Lentiviral Vector In Gene Therapy Revenue Forecast by Type (2022-2027) 4.2.3 Lentiviral Vector In Gene Therapy Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global Lentiviral Vector In Gene Therapy Market Size by Application (2016-2021) 5.1.1 Global Lentiviral Vector In Gene Therapy Sales by Application (2016-2021) 5.1.2 Global Lentiviral Vector In Gene Therapy Revenue by Application (2016-2021) 5.1.3 Lentiviral Vector In Gene Therapy Price by Application (2016-2021) 5.2 Lentiviral Vector In Gene Therapy Market Size Forecast by Application (2022-2027) 5.2.1 Global Lentiviral Vector In Gene Therapy Sales Forecast by Application (2022-2027) 5.2.2 Global Lentiviral Vector In Gene Therapy Revenue Forecast by Application (2022-2027) 5.2.3 Global Lentiviral Vector In Gene Therapy Price Forecast by Application (2022-2027) 6 China by Players, Type and Application 6.1 China Lentiviral Vector In Gene Therapy Market Size YoY Growth 2016-2027 6.1.1 China Lentiviral Vector In Gene Therapy Sales YoY Growth 2016-2027 6.1.2 China Lentiviral Vector In Gene Therapy Revenue YoY Growth 2016-2027 6.1.3 China Lentiviral Vector In Gene Therapy Market Share in Global Market 2016-2027 6.2 China Lentiviral Vector In Gene Therapy Market Size by Players (International and Local Players) 6.2.1 China Top Lentiviral Vector In Gene Therapy Players by Sales (2016-2021) 6.2.2 China Top Lentiviral Vector In Gene Therapy Players by Revenue (2016-2021) 6.3 China Lentiviral Vector In Gene Therapy Historic Market Review by Type (2016-2021) 6.3.1 China Lentiviral Vector In Gene Therapy Sales Market Share by Type (2016-2021) 6.3.2 China Lentiviral Vector In Gene Therapy Revenue Market Share by Type (2016-2021) 6.3.3 China Lentiviral Vector In Gene Therapy Price by Type (2016-2021) 6.4 China Lentiviral Vector In Gene Therapy Market Estimates and Forecasts by Type (2022-2027) 6.4.1 China Lentiviral Vector In Gene Therapy Sales Forecast by Type (2022-2027) 6.4.2 China Lentiviral Vector In Gene Therapy Revenue Forecast by Type (2022-2027) 6.4.3 China Lentiviral Vector In Gene Therapy Price Forecast by Type (2022-2027) 6.5 China Lentiviral Vector In Gene Therapy Historic Market Review by Application (2016-2021) 6.5.1 China Lentiviral Vector In Gene Therapy Sales Market Share by Application (2016-2021) 6.5.2 China Lentiviral Vector In Gene Therapy Revenue Market Share by Application (2016-2021) 6.5.3 China Lentiviral Vector In Gene Therapy Price by Application (2016-2021) 6.6 China Lentiviral Vector In Gene Therapy Market Estimates and Forecasts by Application (2022-2027) 6.6.1 China Lentiviral Vector In Gene Therapy Sales Forecast by Application (2022-2027) 6.6.2 China Lentiviral Vector In Gene Therapy Revenue Forecast by Application (2022-2027) 6.6.3 China Lentiviral Vector In Gene Therapy Price Forecast by Application (2022-2027) 7 North America 7.1 North America Lentiviral Vector In Gene Therapy Market Size YoY Growth 2016-2027 7.2 North America Lentiviral Vector In Gene Therapy Market Facts & Figures by Country 7.2.1 North America Lentiviral Vector In Gene Therapy Sales by Country (2016-2021) 7.2.2 North America Lentiviral Vector In Gene Therapy Revenue by Country (2016-2021) 7.2.3 U.S. 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific Lentiviral Vector In Gene Therapy Market Size YoY Growth 2016-2027 8.2 Asia Pacific Lentiviral Vector In Gene Therapy Market Facts & Figures by Region 8.2.1 Asia Pacific Lentiviral Vector In Gene Therapy Sales by Region (2016-2021) 8.2.2 Asia Pacific Lentiviral Vector In Gene Therapy Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 8.2.12 Philippines 8.2.13 Vietnam 9 Europe 9.1 Europe Lentiviral Vector In Gene Therapy Market Size YoY Growth 2016-2027 9.2 Europe Lentiviral Vector In Gene Therapy Market Facts & Figures by Country 9.2.1 Europe Lentiviral Vector In Gene Therapy Sales by Country (2016-2021) 9.2.2 Europe Lentiviral Vector In Gene Therapy Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America Lentiviral Vector In Gene Therapy Market Size YoY Growth 2016-2027 10.2 Latin America Lentiviral Vector In Gene Therapy Market Facts & Figures by Country 10.2.1 Latin America Lentiviral Vector In Gene Therapy Sales by Country (2016-2021) 10.2.2 Latin America Lentiviral Vector In Gene Therapy Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Lentiviral Vector In Gene Therapy Market Size YoY Growth 2016-2027 11.2 Middle East and Africa Lentiviral Vector In Gene Therapy Market Facts & Figures by Country 11.2.1 Middle East and Africa Lentiviral Vector In Gene Therapy Sales by Country (2016-2021) 11.2.2 Middle East and Africa Lentiviral Vector In Gene Therapy Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 UAE 12 Company Profiles 12.1 Thermo Fisher Scientific Sirion-Biotech GmbH 12.1.1 Thermo Fisher Scientific Sirion-Biotech GmbH Corporation Information 12.1.2 Thermo Fisher Scientific Sirion-Biotech GmbH Description and Business Overview 12.1.3 Thermo Fisher Scientific Sirion-Biotech GmbH Lentiviral Vector In Gene Therapy Sales, Revenue and Gross Margin (2016-2021) 12.1.4 Thermo Fisher Scientific Sirion-Biotech GmbH Lentiviral Vector In Gene Therapy Products Offered 12.1.5 Thermo Fisher Scientific Sirion-Biotech GmbH Recent Development 12.2 Vigene Biosciences 12.2.1 Vigene Biosciences Corporation Information 12.2.2 Vigene Biosciences Description and Business Overview 12.2.3 Vigene Biosciences Lentiviral Vector In Gene Therapy Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Vigene Biosciences Lentiviral Vector In Gene Therapy Products Offered 12.2.5 Vigene Biosciences Recent Development 12.3 OriGene Technologies 12.3.1 OriGene Technologies Corporation Information 12.3.2 OriGene Technologies Description and Business Overview 12.3.3 OriGene Technologies Lentiviral Vector In Gene Therapy Sales, Revenue and Gross Margin (2016-2021) 12.3.4 OriGene Technologies Lentiviral Vector In Gene Therapy Products Offered 12.3.5 OriGene Technologies Recent Development 12.4 SignaGen Laboratories 12.4.1 SignaGen Laboratories Corporation Information 12.4.2 SignaGen Laboratories Description and Business Overview 12.4.3 SignaGen Laboratories Lentiviral Vector In Gene Therapy Sales, Revenue and Gross Margin (2016-2021) 12.4.4 SignaGen Laboratories Lentiviral Vector In Gene Therapy Products Offered 12.4.5 SignaGen Laboratories Recent Development 12.5 Takara Bio 12.5.1 Takara Bio Corporation Information 12.5.2 Takara Bio Description and Business Overview 12.5.3 Takara Bio Lentiviral Vector In Gene Therapy Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Takara Bio Lentiviral Vector In Gene Therapy Products Offered 12.5.5 Takara Bio Recent Development 12.6 Cell Biolabs 12.6.1 Cell Biolabs Corporation Information 12.6.2 Cell Biolabs Description and Business Overview 12.6.3 Cell Biolabs Lentiviral Vector In Gene Therapy Sales, Revenue and Gross Margin (2016-2021) 12.6.4 Cell Biolabs Lentiviral Vector In Gene Therapy Products Offered 12.6.5 Cell Biolabs Recent Development 12.7 GenTarget 12.7.1 GenTarget Corporation Information 12.7.2 GenTarget Description and Business Overview 12.7.3 GenTarget Lentiviral Vector In Gene Therapy Sales, Revenue and Gross Margin (2016-2021) 12.7.4 GenTarget Lentiviral Vector In Gene Therapy Products Offered 12.7.5 GenTarget Recent Development 12.8 GENEMEDI 12.8.1 GENEMEDI Corporation Information 12.8.2 GENEMEDI Description and Business Overview 12.8.3 GENEMEDI Lentiviral Vector In Gene Therapy Sales, Revenue and Gross Margin (2016-2021) 12.8.4 GENEMEDI Lentiviral Vector In Gene Therapy Products Offered 12.8.5 GENEMEDI Recent Development 12.9 Bluebird Bio 12.9.1 Bluebird Bio Corporation Information 12.9.2 Bluebird Bio Description and Business Overview 12.9.3 Bluebird Bio Lentiviral Vector In Gene Therapy Sales, Revenue and Gross Margin (2016-2021) 12.9.4 Bluebird Bio Lentiviral Vector In Gene Therapy Products Offered 12.9.5 Bluebird Bio Recent Development 12.11 Thermo Fisher Scientific Sirion-Biotech GmbH 12.11.1 Thermo Fisher Scientific Sirion-Biotech GmbH Corporation Information 12.11.2 Thermo Fisher Scientific Sirion-Biotech GmbH Description and Business Overview 12.11.3 Thermo Fisher Scientific Sirion-Biotech GmbH Lentiviral Vector In Gene Therapy Sales, Revenue and Gross Margin (2016-2021) 12.11.4 Thermo Fisher Scientific Sirion-Biotech GmbH Lentiviral Vector In Gene Therapy Products Offered 12.11.5 Thermo Fisher Scientific Sirion-Biotech GmbH Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Lentiviral Vector In Gene Therapy Industry Trends 13.2 Lentiviral Vector In Gene Therapy Market Drivers 13.3 Lentiviral Vector In Gene Therapy Market Challenges 13.4 Lentiviral Vector In Gene Therapy Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Lentiviral Vector In Gene Therapy Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Global Lentiviral Vector In Gene Therapy Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of Retrovirus (RV) Table 3. Major Manufacturers of Adenovirus (AdV) Table 4. Major Manufacturers of Adeno-associated Virus (AAV) Table 5. Global Lentiviral Vector In Gene Therapy Market Size Growth Rate by Application (2021-2027) & (K Units) Table 6. Global Lentiviral Vector In Gene Therapy Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027 Table 7. Global Lentiviral Vector In Gene Therapy Sales by Regions (2016-2021) & (K Units) Table 8. Global Lentiviral Vector In Gene Therapy Sales Market Share by Regions (2016-2021) Table 9. Global Lentiviral Vector In Gene Therapy Revenue by Regions (2016-2021) & (US$ Million) Table 10. Global Lentiviral Vector In Gene Therapy Sales Forecast by Region (2022-2027) & (K Units) Table 11. Global Lentiviral Vector In Gene Therapy Sales Market Share Forecast by Region (2022-2027) Table 12. Global Lentiviral Vector In Gene Therapy Revenue Forecast by Region (2022-2027) & (US$ Million) Table 13. Global Lentiviral Vector In Gene Therapy Revenue Market Share Forecast by Region (2022-2027) Table 14. Global Lentiviral Vector In Gene Therapy Sales by Manufacturers (2016-2021) (K Units) Table 15. Global Lentiviral Vector In Gene Therapy Sales Share by Manufacturers (2016-2021) Table 16. Ranking of Global Top Lentiviral Vector In Gene Therapy Manufacturers by Revenue (US$ Million) in 2020 Table 17. Lentiviral Vector In Gene Therapy Revenue by Manufacturers (2016-2021) (US$ Million) Table 18. Lentiviral Vector In Gene Therapy Revenue Share by Manufacturers (2016-2021) Table 19. Global Lentiviral Vector In Gene Therapy Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) Table 20. Global Lentiviral Vector In Gene Therapy by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lentiviral Vector In Gene Therapy as of 2020) Table 21. Key Manufacturers Lentiviral Vector In Gene Therapy Price (2016-2021) (US$/Unit) Table 22. Lentiviral Vector In Gene Therapy Manufacturers Manufacturing Base Distribution and Headquarters Table 23. Manufacturers Lentiviral Vector In Gene Therapy Product Type Table 24. Date of International Manufacturers Enter into Lentiviral Vector In Gene Therapy Market Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans Table 26. Global Lentiviral Vector In Gene Therapy Sales by Type (2016-2021) (K Units) Table 27. Global Lentiviral Vector In Gene Therapy Sales Share by Type (2016-2021) Table 28. Global Lentiviral Vector In Gene Therapy Revenue by Type (2016-2021) (US$ Million) Table 29. Global Lentiviral Vector In Gene Therapy Revenue Share by Type (2016-2021) Table 30. Lentiviral Vector In Gene Therapy Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit) Table 31. Global Lentiviral Vector In Gene Therapy Sales Forecast by Type (2022-2027) & (K Units) Table 32. Global Lentiviral Vector In Gene Therapy Sales Market Share Forecast by Type (2022-2027) Table 33. Global Lentiviral Vector In Gene Therapy Revenue Forecast V (2022-2027) & (US$ Million) Table 34. Global Lentiviral Vector In Gene Therapy Revenue Market Share Forecast by Type (2022-2027) Table 35. Global Lentiviral Vector In Gene Therapy Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit) Table 36. Global Lentiviral Vector In Gene Therapy Sales by Application (2016-2021) (K Units) Table 37. Global Lentiviral Vector In Gene Therapy Sales Share by Application (2016-2021) Table 38. Global Lentiviral Vector In Gene Therapy Revenue by Application (2016-2021) (US$ Million) Table 39. Global Lentiviral Vector In Gene Therapy Revenue Share by Application (2016-2021) Table 40. Lentiviral Vector In Gene Therapy Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit) Table 41. Global Lentiviral Vector In Gene Therapy Sales Forecast by Application (2022-2027) & (K Units) Table 42. Global Lentiviral Vector In Gene Therapy Sales Market Share Forecast by Application (2022-2027) Table 43. Global Lentiviral Vector In Gene Therapy Revenue Forecast by Application (2022-2027) & (US$ Million) Table 44. Global Lentiviral Vector In Gene Therapy Revenue Market Share Forecast by Application (2022-2027) Table 45. Global Lentiviral Vector In Gene Therapy Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit) Table 46. China Lentiviral Vector In Gene Therapy Sales (K Units) of Key Companies (2016-2021) Table 47. China Lentiviral Vector In Gene Therapy Sales Share by Company (2016-2021) Table 48. China Lentiviral Vector In Gene Therapy Revenue (US$ Million) by Company (2016-2021) Table 49. China Lentiviral Vector In Gene Therapy Revenue Share by Company (2016-2021) Table 50. China Lentiviral Vector In Gene Therapy Sales (K Units) by Type (2016-2021) Table 51. China Lentiviral Vector In Gene Therapy Sales Share by Type (2016-2021) Table 52. China Lentiviral Vector In Gene Therapy Revenue (US$ Million) Market Share by Type (2016-2021) Table 53. China Lentiviral Vector In Gene Therapy Price (US$/Unit) by Type (2016-2021) Table 54. China Lentiviral Vector In Gene Therapy Sales (K Units) by Type (2022-2027) Table 55. China Lentiviral Vector In Gene Therapy Sales Share by Type (2022-2027) Table 56. China Lentiviral Vector In Gene Therapy Revenue (US$ Million) Market Share by Type (2022-2027) Table 57. China Lentiviral Vector In Gene Therapy Revenue Share by Type (2022-2027) Table 58. China Lentiviral Vector In Gene Therapy Price (US$/Unit) by Type (2022-2027) Table 59. China Lentiviral Vector In Gene Therapy Sales (K Units) by Application (2016-2021) Table 60. China Lentiviral Vector In Gene Therapy Sales Share by Application (2016-2021) Table 61. China Lentiviral Vector In Gene Therapy Revenue (US$ Million) Market Share by Application (2016-2021) Table 62. China Lentiviral Vector In Gene Therapy Price (US$/Unit) by Application (2016-2021) Table 63. China Lentiviral Vector In Gene Therapy Sales (K Units) by Application (2022-2027) Table 64. China Lentiviral Vector In Gene Therapy Sales Share by Application (2022-2027) Table 65. China Lentiviral Vector In Gene Therapy Revenue (US$ Million) Market Share by Application (2022-2027) Table 66. China Lentiviral Vector In Gene Therapy Revenue Share by Application (2022-2027) Table 67. China Lentiviral Vector In Gene Therapy Price (US$/Unit) by Application (2022-2027) Table 68. North America Lentiviral Vector In Gene Therapy Sales by Country (2016-2021) & (K Units) Table 69. North America Lentiviral Vector In Gene Therapy Sales Market Share by Country (2016-2021) Table 70. North America Lentiviral Vector In Gene Therapy Revenue by Country (2016-2021) & (US$ Million) Table 71. North America Lentiviral Vector In Gene Therapy Revenue Market Share by Country (2016-2021) Table 72. Asia Pacific Lentiviral Vector In Gene Therapy Sales by Region (2016-2021) & (K Units) Table 73. Asia Pacific Lentiviral Vector In Gene Therapy Sales Market Share by Region (2016-2021) Table 74. Asia Pacific Lentiviral Vector In Gene Therapy Revenue by Region (2016-2021) & (US$ Million) Table 75. Asia Pacific Lentiviral Vector In Gene Therapy Revenue Market Share by Region (2016-2021) Table 76. Europe Lentiviral Vector In Gene Therapy Sales by Country (2016-2021) & (K Units) Table 77. Europe Lentiviral Vector In Gene Therapy Sales Market Share by Country (2016-2021) Table 78. Europe Lentiviral Vector In Gene Therapy Revenue by Country (2016-2021) & (US$ Million) Table 79. Europe Lentiviral Vector In Gene Therapy Revenue Market Share by Country (2016-2021) Table 80. Latin America Lentiviral Vector In Gene Therapy Sales by Country (2016-2021) & (K Units) Table 81. Latin America Lentiviral Vector In Gene Therapy Sales Market Share by Country (2016-2021) Table 82. Latin Americaa Lentiviral Vector In Gene Therapy Revenue by Country (2016-2021) & (US$ Million) Table 83. Latin America Lentiviral Vector In Gene Therapy Revenue Market Share by Country (2016-2021) Table 84. Middle East and Africa Lentiviral Vector In Gene Therapy Sales by Country (2016-2021) & (K Units) Table 85. Middle East and Africa Lentiviral Vector In Gene Therapy Sales Market Share by Country (2016-2021) Table 86. Middle East and Africa Lentiviral Vector In Gene Therapy Revenue by Country (2016-2021) & (US$ Million) Table 87. Middle East and Africa Lentiviral Vector In Gene Therapy Revenue Market Share by Country (2016-2021) Table 88. Thermo Fisher Scientific Sirion-Biotech GmbH Corporation Information Table 89. Thermo Fisher Scientific Sirion-Biotech GmbH Description and Business Overview Table 90. Thermo Fisher Scientific Sirion-Biotech GmbH Lentiviral Vector In Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 91. Thermo Fisher Scientific Sirion-Biotech GmbH Lentiviral Vector In Gene Therapy Product Table 92. Thermo Fisher Scientific Sirion-Biotech GmbH Recent Development Table 93. Vigene Biosciences Corporation Information Table 94. Vigene Biosciences Description and Business Overview Table 95. Vigene Biosciences Lentiviral Vector In Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 96. Vigene Biosciences Product Table 97. Vigene Biosciences Recent Development Table 98. OriGene Technologies Corporation Information Table 99. OriGene Technologies Description and Business Overview Table 100. OriGene Technologies Lentiviral Vector In Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 101. OriGene Technologies Product Table 102. OriGene Technologies Recent Development Table 103. SignaGen Laboratories Corporation Information Table 104. SignaGen Laboratories Description and Business Overview Table 105. SignaGen Laboratories Lentiviral Vector In Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 106. SignaGen Laboratories Product Table 107. SignaGen Laboratories Recent Development Table 108. Takara Bio Corporation Information Table 109. Takara Bio Description and Business Overview Table 110. Takara Bio Lentiviral Vector In Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 111. Takara Bio Product Table 112. Takara Bio Recent Development Table 113. Cell Biolabs Corporation Information Table 114. Cell Biolabs Description and Business Overview Table 115. Cell Biolabs Lentiviral Vector In Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 116. Cell Biolabs Product Table 117. Cell Biolabs Recent Development Table 118. GenTarget Corporation Information Table 119. GenTarget Description and Business Overview Table 120. GenTarget Lentiviral Vector In Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 121. GenTarget Product Table 122. GenTarget Recent Development Table 123. GENEMEDI Corporation Information Table 124. GENEMEDI Description and Business Overview Table 125. GENEMEDI Lentiviral Vector In Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 126. GENEMEDI Product Table 127. GENEMEDI Recent Development Table 128. Bluebird Bio Corporation Information Table 129. Bluebird Bio Description and Business Overview Table 130. Bluebird Bio Lentiviral Vector In Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 131. Bluebird Bio Product Table 132. Bluebird Bio Recent Development Table 133. Lentiviral Vector In Gene Therapy Market Trends Table 134. Lentiviral Vector In Gene Therapy Market Drivers Table 135. Lentiviral Vector In Gene Therapy Market Challenges Table 136. Lentiviral Vector In Gene Therapy Market Restraints Table 137. Lentiviral Vector In Gene Therapy Customers List Table 138. Lentiviral Vector In Gene Therapy Distributors List Table 139. Research Programs/Design for This Report Table 140. Key Data Information from Secondary Sources Table 141. Key Data Information from Primary Sources List of Figures Figure 1. Lentiviral Vector In Gene Therapy Product Picture Figure 2. Global Lentiviral Vector In Gene Therapy Sales Market Share by Type in 2020 & 2027 Figure 3. Retrovirus (RV) Product Picture Figure 4. Adenovirus (AdV) Product Picture Figure 5. Adeno-associated Virus (AAV) Product Picture Figure 6. Global Lentiviral Vector In Gene Therapy Sales Market Share by Application in 2020 & 2027 Figure 7. Hospital Figure 8. Clinic Figure 9. Research Institution Figure 10. Others Figure 11. Lentiviral Vector In Gene Therapy Report Years Considered Figure 12. Global Lentiviral Vector In Gene Therapy Market Size, (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Lentiviral Vector In Gene Therapy Market Size 2016-2027 (US$ Million) Figure 14. Global Lentiviral Vector In Gene Therapy Sales 2016-2027 (K Units) Figure 15. Global Lentiviral Vector In Gene Therapy Market Size Market Share by Region: 2021 Versus 2027 Figure 16. Global Lentiviral Vector In Gene Therapy Sales Market Share by Region (2016-2021) Figure 17. Global Lentiviral Vector In Gene Therapy Sales Market Share by Region in 2020 Figure 18. Global Lentiviral Vector In Gene Therapy Revenue Market Share by Region (2016-2021) Figure 19. Global Lentiviral Vector In Gene Therapy Revenue Market Share by Region in 2020 Figure 20. Global Lentiviral Vector In Gene Therapy Sales Share by Manufacturer in 2020 Figure 21. The Top 10 and 5 Players Market Share by Lentiviral Vector In Gene Therapy Revenue in 2020 Figure 22. Lentiviral Vector In Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 23. Global Lentiviral Vector In Gene Therapy Sales Market Share by Type (2016-2021) Figure 24. Global Lentiviral Vector In Gene Therapy Sales Market Share by Type in 2020 Figure 25. Global Lentiviral Vector In Gene Therapy Revenue Market Share by Type (2016-2021) Figure 26. Global Lentiviral Vector In Gene Therapy Revenue Market Share by Type in 2020 Figure 27. Global Lentiviral Vector In Gene Therapy Sales Market Share by Application (2016-2021) Figure 28. Global Lentiviral Vector In Gene Therapy Sales Market Share by Application in 2020 Figure 29. Global Lentiviral Vector In Gene Therapy Revenue Market Share by Application (2016-2021) Figure 30. Global Lentiviral Vector In Gene Therapy Revenue Market Share by Application in 2020 Figure 31. China Lentiviral Vector In Gene Therapy Sales Growth Rate 2016-2027 (K Units) Figure 32. China Lentiviral Vector In Gene Therapy Revenue Growth Rate 2016-2027 (US$ Million) Figure 33. China Lentiviral Vector In Gene Therapy Market Share in Global Market 2016-2027 Figure 34. China 5 and 10 Largest Lentiviral Vector In Gene Therapy Players Market Share by Revenue in Lentiviral Vector In Gene Therapy in 2020 Figure 35. China Lentiviral Vector In Gene Therapy Revenue Share by Type (2016-2021) Figure 36. China Lentiviral Vector In Gene Therapy Revenue Growth Rate by Type in 2016 & 2020 Figure 37. China Lentiviral Vector In Gene Therapy Revenue Share by Application (2016-2021) Figure 38. China Lentiviral Vector In Gene Therapy Revenue Growth Rate by Application in 2016 & 2020 Figure 39. North America Lentiviral Vector In Gene Therapy Sales Growth Rate 2016-2021 (K Units) Figure 40. North America Lentiviral Vector In Gene Therapy Revenue Growth Rate 2016-2021 (US$ Million) Figure 41. North America Lentiviral Vector In Gene Therapy Sales Market Share by Country in 2020 Figure 42. North America Lentiviral Vector In Gene Therapy Revenue Market Share by Country in 2020 Figure 43. U.S. Lentiviral Vector In Gene Therapy Sales Growth Rate (2016-2021) (K Units) Figure 44. U.S. Lentiviral Vector In Gene Therapy Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Canada Lentiviral Vector In Gene Therapy Sales Growth Rate (2016-2021) (K Units) Figure 46. Canada Lentiviral Vector In Gene Therapy Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. Europe Lentiviral Vector In Gene Therapy Sales Growth Rate 2016-2021 (K Units) Figure 48. Europe Lentiviral Vector In Gene Therapy Revenue Growth Rate 2016-2021 (US$ Million) Figure 49. Europe Lentiviral Vector In Gene Therapy Sales Market Share by Country in 2020 Figure 50. Europe Lentiviral Vector In Gene Therapy Revenue Market Share by Country in 2020 Figure 51. Germany Lentiviral Vector In Gene Therapy Sales Growth Rate (2016-2021) (K Units) Figure 52. Germany Lentiviral Vector In Gene Therapy Revenue Growth Rate (2016-2021) (US$ Million) Figure 53. France Lentiviral Vector In Gene Therapy Sales Growth Rate (2016-2021) (K Units) Figure 54. France Lentiviral Vector In Gene Therapy Revenue Growth Rate (2016-2021) (US$ Million) Figure 55. U.K. Lentiviral Vector In Gene Therapy Sales Growth Rate (2016-2021) (K Units) Figure 56. U.K. Lentiviral Vector In Gene Therapy Revenue Growth Rate (2016-2021) (US$ Million) Figure 57. Italy Lentiviral Vector In Gene Therapy Sales Growth Rate (2016-2021) (K Units) Figure 58. Italy Lentiviral Vector In Gene Therapy Revenue Growth Rate (2016-2021) (US$ Million) Figure 59. Russia Lentiviral Vector In Gene Therapy Sales Growth Rate (2016-2021) (K Units) Figure 60. Russia Lentiviral Vector In Gene Therapy Revenue Growth Rate (2016-2021) (US$ Million) Figure 61. Asia Pacific Lentiviral Vector In Gene Therapy Sales Growth Rate 2016-2021 (K Units) Figure 62. Asia Pacific Lentiviral Vector In Gene Therapy Revenue Growth Rate 2016-2021 (US$ Million) Figure 63. Asia Pacific Lentiviral Vector In Gene Therapy Sales Market Share by Region in 2020 Figure 64. Asia Pacific Lentiviral Vector In Gene Therapy Revenue Market Share by Region in 2020 Figure 65. China Lentiviral Vector In Gene Therapy Sales Growth Rate (2016-2021) (K Units) Figure 66. China Lentiviral Vector In Gene Therapy Revenue Growth Rate (2016-2021) (US$ Million) Figure 67. Japan Lentiviral Vector In Gene Therapy Sales Growth Rate (2016-2021) (K Units) Figure 68. Japan Lentiviral Vector In Gene Therapy Revenue Growth Rate (2016-2021) (US$ Million) Figure 69. South Korea Lentiviral Vector In Gene Therapy Sales Growth Rate (2016-2021) (K Units) Figure 70. South Korea Lentiviral Vector In Gene Therapy Revenue Growth Rate (2016-2021) (US$ Million) Figure 71. India Lentiviral Vector In Gene Therapy Sales Growth Rate (2016-2021) (K Units) Figure 72. India Lentiviral Vector In Gene Therapy Revenue Growth Rate (2016-2021) (US$ Million) Figure 73. Australia Lentiviral Vector In Gene Therapy Sales Growth Rate (2016-2021) (K Units) Figure 74. Australia Lentiviral Vector In Gene Therapy Revenue Growth Rate (2016-2021) (US$ Million) Figure 75. Taiwan Lentiviral Vector In Gene Therapy Sales Growth Rate (2016-2021) (K Units) Figure 76. Taiwan Lentiviral Vector In Gene Therapy Revenue Growth Rate (2016-2021) (US$ Million) Figure 77. Indonesia Lentiviral Vector In Gene Therapy Sales Growth Rate (2016-2021) (K Units) Figure 78. Indonesia Lentiviral Vector In Gene Therapy Revenue Growth Rate (2016-2021) (US$ Million) Figure 79. Thailand Lentiviral Vector In Gene Therapy Sales Growth Rate (2016-2021) (K Units) Figure 80. Thailand Lentiviral Vector In Gene Therapy Revenue Growth Rate (2016-2021) (US$ Million) Figure 81. Malaysia Lentiviral Vector In Gene Therapy Sales Growth Rate (2016-2021) (K Units) Figure 82. Malaysia Lentiviral Vector In Gene Therapy Revenue Growth Rate (2016-2021) (US$ Million) Figure 83. Philippines Lentiviral Vector In Gene Therapy Sales Growth Rate (2016-2021) (K Units) Figure 84. Philippines Lentiviral Vector In Gene Therapy Revenue Growth Rate (2016-2021) (US$ Million) Figure 85. Vietnam Lentiviral Vector In Gene Therapy Sales Growth Rate (2016-2021) (K Units) Figure 86. Vietnam Lentiviral Vector In Gene Therapy Revenue Growth Rate (2016-2021) (US$ Million) Figure 87. Latin America Lentiviral Vector In Gene Therapy Sales Growth Rate 2016-2021 (K Units) Figure 88. Latin America Lentiviral Vector In Gene Therapy Revenue Growth Rate 2016-2021 (US$ Million) Figure 89. Latin America Lentiviral Vector In Gene Therapy Sales Market Share by Country in 2020 Figure 90. Latin America Lentiviral Vector In Gene Therapy Revenue Market Share by Country in 2020 Figure 91. Mexico Lentiviral Vector In Gene Therapy Sales Growth Rate (2016-2021) (K Units) Figure 92. Mexico Lentiviral Vector In Gene Therapy Revenue Growth Rate (2016-2021) (US$ Million) Figure 93. Brazil Lentiviral Vector In Gene Therapy Sales Growth Rate (2016-2021) (K Units) Figure 94. Brazil Lentiviral Vector In Gene Therapy Revenue Growth Rate (2016-2021) (US$ Million) Figure 95. Argentina Lentiviral Vector In Gene Therapy Sales Growth Rate (2016-2021) (K Units) Figure 96. Argentina Lentiviral Vector In Gene Therapy Revenue Growth Rate (2016-2021) (US$ Million) Figure 97. Middle East and Africa Lentiviral Vector In Gene Therapy Sales Growth Rate 2016-2021 (K Units) Figure 98. Middle East and Africa Lentiviral Vector In Gene Therapy Revenue Growth Rate 2016-2021 (US$ Million) Figure 99. Middle East and Africa Lentiviral Vector In Gene Therapy Sales Market Share by Country in 2020 Figure 100. Middle East and Africa Lentiviral Vector In Gene Therapy Revenue Market Share by Country in 2020 Figure 101. Turkey Lentiviral Vector In Gene Therapy Sales Growth Rate (2016-2021) (K Units) Figure 102. Turkey Lentiviral Vector In Gene Therapy Revenue Growth Rate (2016-2021) (US$ Million) Figure 103. Saudi Arabia Lentiviral Vector In Gene Therapy Sales Growth Rate (2016-2021) (K Units) Figure 104. Saudi Arabia Lentiviral Vector In Gene Therapy Revenue Growth Rate (2016-2021) (US$ Million) Figure 105. UAE Lentiviral Vector In Gene Therapy Sales Growth Rate (2016-2021) (K Units) Figure 106. UAE Lentiviral Vector In Gene Therapy Revenue Growth Rate (2016-2021) (US$ Million) Figure 107. Lentiviral Vector In Gene Therapy Value Chain Figure 108. Channels of Distribution Figure 109. Distributors Profiles Figure 110. Bottom-up and Top-down Approaches for This Report Figure 111. Data Triangulation Figure 112. Key Executives Interviewed

Thermo Fisher Scientific Sirion-Biotech GmbH Vigene Biosciences OriGene Technologies SignaGen Laboratories Takara Bio Cell Biolabs GenTarget GENEMEDI Bluebird Bio